drugset
drugset / Trial / NCT04713254

Drug Drug Interaction Study With Lu AG06466 in Young Healthy Men

NCT04713254 ↗

Phase 1 Completed 15 enrolled H. Lundbeck A/S
NaSequentialOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effect of repeated doses of the drug Lu AG06466 on the exposure of metoprolol, midazolam and bupropion

Timeline

Start
2020-12-08
Primary completion
2021-04-09
Completion
2021-04-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Lu AG06466 Unknown 10 mg Oral
Subject Lu AG06466 Unknown 20 mg Oral
Subject Lu AG06466 Unknown 30 mg Oral

Indications

No indication recorded.